Rockwell Medical (RMTI) Cash from Operations Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | 27.85% |
| 10 | Rockwell Medical | 28.43 Mn | 4.54 Mn | 2.90 Mn | 62.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.77% |
| Dec 31, 2025 | 180.58% |
| Sep 30, 2025 | -7.00% |
| Jun 30, 2025 | 32.37% |
| Mar 31, 2025 | 29.17% |
| Dec 31, 2024 | 27.97% |
| Sep 30, 2024 | 37.58% |
| Jun 30, 2024 | 31.85% |
| Mar 31, 2024 | 42.46% |
| Dec 31, 2023 | 82.88% |
| Sep 30, 2023 | 8.62% |
| Jun 30, 2023 | 43.44% |
| Mar 31, 2023 | 15.99% |
| Dec 31, 2022 | 72.35% |
| Sep 30, 2022 | 43.70% |
| Jun 30, 2022 | 17.08% |
| Mar 31, 2022 | -21.84% |
| Dec 31, 2021 | -15.99% |
| Sep 30, 2021 | -13.97% |
| Jun 30, 2021 | 2.02% |